IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer
NCT01237665
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DRUG:
IXO regimen
Sponsor
Ottawa Hospital Research Institute
Collaborators
[object Object]
[object Object]
[object Object]